A detailed history of Intech Investment Management LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 32,653 shares of ARVN stock, worth $345,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,653
Previous 31,528 3.57%
Holding current value
$345,142
Previous $232,000 19.83%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$6.24 - $8.53 $7,020 - $9,596
1,125 Added 3.57%
32,653 $278,000
Q2 2025

Aug 08, 2025

SELL
$6.07 - $9.62 $90,928 - $144,107
-14,980 Reduced 32.21%
31,528 $232,000
Q1 2025

May 20, 2025

BUY
$7.02 - $20.5 $156,939 - $458,298
22,356 Added 92.56%
46,508 $326,000
Q4 2024

Feb 10, 2025

BUY
$17.83 - $28.04 $176,980 - $278,325
9,926 Added 69.77%
24,152 $462,000
Q3 2024

Nov 08, 2024

BUY
$23.66 - $32.73 $336,587 - $465,616
14,226 New
14,226 $350,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $562M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.